Advertisement

Topics

CENTRE D’IMMUNOLOGIE PIERRE FABRE Company Profile

15:32 EST 10th December 2018 | BioPortfolio

Located in France, close to the biotech heart of Geneva, the CIPF is a part of Pierre FABRE Laboratories (over 9000 people in France and overseas).
Created in 1990, our Research Centre - 100 collaborators - is dedicated to the discovery, development and production of antibody-based molecules to treat cancer. Combining multiple research expertise in experimental oncology, genetic engineering, molecular and cellular biology, and biochemistry, together with a sound know-how in antibody humanization, cellular imaging, molecular modelling and bioinformatics.

In addition, the CIPF possesses an Industrial Pilot plant dedicated to process development and production of recombinant molecules of therapeutic interest.

Location

5,avenue Napoléon III
St Julien en
Genevois Cedex,
BP 497, 74164
France

Contact

Phone: 33 4.50.35.35.55
Fax: 33 4.50.35.35.90
Email: alain.dorison@pierre-fabre.com


News Articles [407 Associated News Articles listed on BioPortfolio]

Pierre Fabre gets CHMP positive opinion for melanoma therapy

Pierre Fabre has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European...Read More... The post Pierre Fabre gets CHMP positive opinion for melanoma...

Appointments: Top-Level Changes At J&J, Roche, Pierre Fabre, Nordic Nanovector, Inthera And DDF

This week's announcements include changes at the top of Johnson & Johnson, Roche, Pierre Fabre, Nordic Nanovector, Inthera Bioscience and...  

CrownBio, Pierre Fabre In Immuno-Oncology Alliance

CrownBio to engraft PDX models selected by Pierre Fabre into CD34+ humanized mouse models

Pierre Fabre, Array showcase potential of triple therapy for CRC

Pierre Fabre and Array BioPharma have unveiled data from a late-stage trial showing a significant improvement in one-year survival in colorectal cancer patients taking encorafenib, binimetinib and cet...

FDA approves Pierre Fabre/Array Biotech melanoma combo

US regulators have issued a green light for Pierre Fabre and Array Biotech’s encorafenib/binimetinib combination therapy for advanced BRAF-mutant melanoma.

Pierre Fabre to launch blockchain patient engagement pilot

Pierre Fabre Pharmaceuticals has joined a blockchain consortium that allows patients to share real-time digital health data to inform late-stage clinical research. The French pharma company will work...

Pierre Fabre & Array BioPharma Announce a 62% Observed OS at One Year from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant CRC at the ESMO GI Congress

Median Overall Survival (mOS) was not reached; OS data are fully mature through 12.6 months Not intended for UK- and US-based media Pierre Fabre and its partner Array BioPharma Inc. today announce...

CrownBio Enters Partnership with Pierre Fabre to Accelerate Discovery and Development of Immuno-Oncology Agents

SAN DIEGO, June 19, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, card...

PubMed Articles [395 Associated PubMed Articles listed on BioPortfolio]

The Sociology of Pierre Bourdieu: theoretical potential for the subfield of nursing.

to approach the basic conceptions of Pierre Bourdieu's sociology and its articulation with the subfield of nursing by focusing on managerial aspects.

A Single Lab Test to Aid Pierre Robin Sequence Severity Diagnosis.

The workup of patients with Pierre Robin sequence (PRS) consists of a physical examination, O saturation, and polysomnography to determine the severity of respiratory obstruction and need for surgery....

Reply to Fabre et. al.

Professor Jean-Pierre Relier.

Pierre Mollaret (1898-1987).

Clinical Trials [1139 Associated Clinical Trials listed on BioPortfolio]

Bioavailability Pilot Study of Versus W0035 Versus Stromectol

Ivermectin is prescribed for the treatment of helminthic infections sensitive to ivermectin. However, it is currently only available as a tablet formulation. W0035 is a powder for oral sus...

Efficacy and Tolerance of D-pigment Versus Moisturizer in Hands' Lentigo Lesions With or Without Laser Therapy

Pierre Fabre Dermo-Cosmétique has commercialized a cosmetic product (D-pigment rich texture) for treatment of hyperpigmentation. The aim of this study is to evaluate the efficacy of D-pig...

Impact of Phonatory and Facial Morphology Disorders, on the Quality of Life of Adolescents With Pierre Robin Sequence

The study team has made the hypothesis that the intensity of the phonatory disorders (rhinolalia), and of the maxillo-mandibular growth anomalies (facial morphology), may have negative eff...

Early Treatment Outcomes in Pierre-Robin-Like Phenotype

In a longitudinal cohort study, we want to assess the effect of the pre-epiglottic baton plate, the main treatment approach currently used in Germany for Pierre-Robin-Like phenotype, on up...

Brainstem Dysfunction Involvement in the Pathogenesis of Pierre Robin Sequence

Introduction Pierre Robin Sequence, PRS, incidence is about one hundred births per year in France. The main neonatal clinical manifestations are secondary to airway obstruction and food di...

Companies [379 Associated Companies listed on BioPortfolio]

Pierre Fabre SA

Pierre Fabre group, France's second biggest independent pharmaceutical laboratory, achieved a turnover of 1.75 billion euros in 2008. Approximatively 10,000 people including 1,400 in the research ...

CENTRE D’IMMUNOLOGIE PIERRE FABRE

Located in France, close to the biotech heart of Geneva, the CIPF is a part of Pierre FABRE Laboratories (over 9000 people in France and overseas). Created in 1990, our Research Centre - 100 collabor...

Groupe Pierre Fabre

The Pierre Fabre Group, the second largest independent French pharmaceutical company and leader in the field of in-pharmacy dermo-cosmetics, employs about 10,000 people worldwide, including 1,400 ...

Laboratoires Pierre Fabre S A

Nil

PIERRE GUERIN S.A.S

Supporting Food and Health industriesA specialist in stainless steel products and a designer and manufacturer of process vessels integrating sophisticated and innovative features in agitation, mixing,...

More Information about "CENTRE D’IMMUNOLOGIE PIERRE FABRE" on BioPortfolio

We have published hundreds of CENTRE D’IMMUNOLOGIE PIERRE FABRE news stories on BioPortfolio along with dozens of CENTRE D’IMMUNOLOGIE PIERRE FABRE Clinical Trials and PubMed Articles about CENTRE D’IMMUNOLOGIE PIERRE FABRE for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CENTRE D’IMMUNOLOGIE PIERRE FABRE Companies in our database. You can also find out about relevant CENTRE D’IMMUNOLOGIE PIERRE FABRE Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record